InnovAge Holding Corp. (INNV)
USD 3.3
(-5.17%)
USD 3.3
(-5.17%)
| Year | Total Assets | Total Assets Growth |
|---|---|---|
| 2024 | 547.66 Million USD | -3.47% |
| 2023 | 567.35 Million USD | 2.12% |
| 2022 | 555.59 Million USD | 4.48% |
| 2021 | 531.75 Million USD | 29.81% |
| 2020 | 409.63 Million USD | 12.77% |
| 2019 | 363.23 Million USD | 0.0% |
| Year | Total Assets | Total Assets Growth |
|---|---|---|
| 2024 Q4 | 547.66 Million USD | 3.85% |
| 2024 Q3 | 527.35 Million USD | -1.29% |
| 2024 Q2 | 534.26 Million USD | -2.08% |
| 2024 FY | 547.66 Million USD | -3.47% |
| 2024 Q1 | 545.59 Million USD | -3.84% |
| 2023 Q3 | 569.4 Million USD | 4.27% |
| 2023 Q2 | 546.11 Million USD | -6.64% |
| 2023 FY | 567.35 Million USD | 2.12% |
| 2023 Q1 | 584.98 Million USD | 5.29% |
| 2023 Q4 | 567.35 Million USD | -0.36% |
| 2022 Q2 | 558 Million USD | 2.79% |
| 2022 Q4 | 555.59 Million USD | -0.46% |
| 2022 Q3 | 558.19 Million USD | 0.03% |
| 2022 Q1 | 542.87 Million USD | 2.09% |
| 2022 FY | 555.59 Million USD | 4.48% |
| 2021 Q2 | 374.7 Million USD | 0.0% |
| 2021 FY | 531.75 Million USD | 29.81% |
| 2021 Q4 | 531.75 Million USD | 0.07% |
| 2021 Q3 | 531.39 Million USD | 41.82% |
| 2020 Q4 | 409.63 Million USD | 0.0% |
| 2020 FY | 409.63 Million USD | 12.77% |
| 2019 FY | 363.23 Million USD | 0.0% |
| Name | Total Assets | Total Assets Difference |
|---|---|---|
| Acadia Healthcare Company, Inc. | 5.35 Billion USD | 89.78% |
| Addus HomeCare Corporation | 1.02 Billion USD | 46.54% |
| AirSculpt Technologies, Inc. | 213.55 Million USD | -156.453% |
| Amedisys, Inc. | 2.06 Billion USD | 73.417% |
| American Oncology Network, Inc. | 374.45 Million USD | -46.256% |
| Astrana Health, Inc. | 933.36 Million USD | 41.324% |
| Aveanna Healthcare Holdings Inc. | 1.63 Billion USD | 66.548% |
| IMAC Holdings, Inc. | 1.14 Million USD | -47767.486% |
| biote Corp. | 155.29 Million USD | -252.658% |
| Cryo-Cell International, Inc. | 61.22 Million USD | -794.567% |
| Cross Country Healthcare, Inc. | 679.31 Million USD | 19.381% |
| COMPASS Pathways plc | 275.98 Million USD | -98.437% |
| DocGo Inc. | 490.45 Million USD | -11.665% |
| The Ensign Group, Inc. | 4.17 Billion USD | 86.89% |
| Healthcare Services Group, Inc. | 803.18 Million USD | 31.814% |
| Assure Holdings Corp. | 7.51 Million USD | -7188.541% |
| The Joint Corp. | 87.15 Million USD | -528.406% |
| LifeStance Health Group, Inc. | 2.23 Billion USD | 75.476% |
| Mobile-health Network Solutions Class A Ordinary Shares | 7.95 Million USD | -6788.285% |
| ModivCare Inc. | 1.76 Billion USD | 69.011% |
| NewGenIvf Group Limited | 1.64 Million USD | -33142.749% |
| Novo Integrated Sciences, Inc. | 35.56 Million USD | -1439.972% |
| Option Care Health, Inc. | 3.32 Billion USD | 83.546% |
| P3 Health Partners Inc. | 860.96 Million USD | 36.39% |
| P3 Health Partners Inc. | 860.96 Million USD | 36.39% |
| The Pennant Group, Inc. | 539.69 Million USD | -1.477% |
| Surgery Partners, Inc. | 7.01 Billion USD | 92.198% |
| Syra Health Corp. Class A Common Stock | 4.92 Million USD | -11023.898% |
| Talkspace, Inc. | 142.22 Million USD | -285.077% |
| Talkspace, Inc. | 142.22 Million USD | -285.077% |
| The Oncology Institute, Inc. | 219.41 Million USD | -149.597% |
| The Oncology Institute, Inc. | 219.41 Million USD | -149.597% |